Form 4 for NKTR NEKTAR THERAPEUTICS

Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001209191-21-070690 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-12-20	2021-12-16	NKTR	Labrucherie Gil M	SVP, COO, CFO	A - Grant	$0.00	+53.0K	309.2K	+21%	$0
D	2021-12-20	2021-12-16	NKTR	Labrucherie Gil M	SVP, COO, CFO	A - Grant	$0.00	+94.0K	94.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-16	A	A	52,950	$0.00	309,182	D	—	—	(F1) This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service. (F2) This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).
2	Derivative	Stock Option	2021-12-16	A	A	94,000	$0.00	94,000	D	$13.22 · — to 2029-12-15	94,000 Common Stock	(F3) This stock option vests over four years from the date of grant in equal monthly installments based on continued service.